TriSalus Life Sciences, Inc. (TLSI)

NGM – Real Time Price. Currency in USD

5.74

-0.01 (-0.09%)

Market open: Aug 12, 2026, 12:33 PM EDT

5.63

-0.11 (-1.92%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

45M

29M

19M

12M

Cost of goods sold

-7M

-5M

-3M

Gross Profit

38M

25M

15M

10M

Operating expenses (excl. COGS)

-65M

-61M

-69M

-45M

Operating Income

-27M

-36M

-53M

-35M

Non-operating income, total

-12M

-6M

-12M

Pretax income

-39M

-30M

-59M

-47M

Equity in earnings

Taxes

-7K

-6K

-9K

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-39M

-30M

-59M

-47M

Discontinued operations

Net income

-39M

-30M

-59M

-47M

Dilution adjustment

Preferred dividends

30M

TriSalus Life Sciences, Inc. (TLSI)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

TriSalus Life Sciences, Inc. (TLSI)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

TriSalus Life Sciences, Inc. (TLSI)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

TriSalus Life Sciences, Inc. (TLSI)

Income Statement (Annual)

Income Statement (Annual)